AW
HUMA icon

Avion Wealth’s Humacyte HUMA Stock Holding History

Avion Wealth’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-299
Closed – – 1409
2025
Q4 		$0 Buy
+299
New +$423 ﹤0.01% 1395

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Avion Wealth's HUMA Position: Q1 2026 in Review

Avion Wealth sold out of Humacyte (HUMA) in Q1 2026, closing a stake of 299 shares.

Avion Wealth first reported a position in HUMA in Q4 2025 and held it in 1 quarter. The position peaked at $0 in Q4 2025. 159 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Avion Wealth reported no remaining Humacyte position as of Q1 2026 after selling out during the quarter.
  • Avion Wealth sold 299 Humacyte shares in Q1 2026.
  • Avion Wealth first reported a position in Humacyte in Q4 2025 and held it in 1 quarter.
  • Avion Wealth's Humacyte position peaked at $0 in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.